Search Results
Sep 10, 2025, 20:30 ET Wesbanco Announces Pricing of $230 Million Offering of Depositary Shares Representing Interests in Preferred Stock
WHEELING, W.Va., Sept. 10, 2025 /PRNewswire/ -- Wesbanco, Inc. (Nasdaq/NGS: WSBC) ("Wesbanco") today announced that it has priced an underwritten public offering of 9,200,000 depositary shares (the "depositary shares") each
More news about: WesBanco, Inc.
Sep 10, 2025, 16:12 ET Prinses Máxima Center for Pediatric Oncology implementiert Callisto™ von Volta Labs zur Rationalisierung klinischer Genomik-Workflows
Einführung von Callisto unterstreicht die weltweit wachsende Nachfrage nach Automatisierungslösungen, die die Effizienz, Genauigkeit und Skalierbarkeit von NGS verbessern. Über das Prinses Máxima Center for Pediatric OncologyDas Prinses Máxima Center for Pediatric Oncology in Utrecht,
More news about: Volta Labs Inc.
Sep 10, 2025, 16:06 ET Prinses Máxima Center for Pediatric Oncology met en œuvre Callisto™ de Volta Labs pour rationaliser les flux de travail en génomique clinique
L'adoption de Callisto souligne la demande mondiale croissante de solutions d'automatisation qui améliorent l'efficacité, la précision et l'évolutivité de la NGS. À propos du Prinses Máxima Center for Pediatric OncologyLe Prinses Máxima Center for Pediatric Oncology, situé à Utrecht,
More news about: Volta Labs Inc.
Sep 10, 2025, 15:14 ET El Centro Princesa Máxima de Oncología Pediátrica implementa Callisto™ de Volta Labs
adopción de Callisto subraya la creciente demanda global de soluciones de automatización que mejoren la eficiencia, la precisión y la escalabilidad de NGS. A erca del Centro Princesa Máxima de Oncología Pediátrica El Centro Princesa Máxima de Oncología Pediátrica, ubicado en
More news about: Volta Labs Inc.
Sep 10, 2025, 13:11 ET Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows
bring insights to these patients faster." The adoption of Callisto underscores the growing global demand for automation solutions that improve NGS efficiency, accuracy, and scalability. About Prinses Máxima Center for Pediatric OncologyThe Prinses Máxima Center for Pediatric
More news about: Volta Labs Inc.
Sep 10, 2025, 13:11 ET Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows
bring insights to these patients faster." The adoption of Callisto underscores the growing global demand for automation solutions that improve NGS efficiency, accuracy, and scalability. About Prinses Máxima Center for Pediatric OncologyThe Prinses Máxima Center for Pediatric
More news about: Volta Labs Inc.
Sep 10, 2025, 10:00 ET Avelo Airlines Orders up to 100 Embraer E195‑E2s to Modernize Fleet, Reduce Cost, and Fuel Growth
aircraft, making this a significant milestone for Embraer's flagship E2 program. The E195‑E2s will modernize Avelo's fleet, complementing its Boeing 737NGs for the foreseeable future while improving cost efficiency and network reach. The E2's excellent short-field performance, enabled by E2TS (Embraer
More news about: Avelo Airlines
Sep 10, 2025, 08:30 ET ePlus Acquires Assets of Realwave, Inc.
HERNDON, Va., Sept. 10, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.